/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
With a market cap of $10 billion, Revvity, Inc. (RVTY) is a global provider of health sciences solutions, technologies, and services. The company delivers a broad portfolio that includes instruments, reagents, informatics, software, imaging technologies, DNA sequencing services, and diagnostic platforms for genetic and infectious disease testing.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Revvity fits this criterion perfectly. Serving pharmaceutical and biotechnology companies, research institutions, healthcare providers, and government agencies, Revvity supports advancements in diagnostics, drug discovery, genomics, and public health.
